The year 2023 has become a new countdown for MedWave in connection with the next direction of our activity – our own production. At the facilities of the national manufacturer JSC “ARTERIUM” and the pharmaceutical factory “Viola”, we are launching the production of our most popular brands. “ARTERIUM is a pharmaceutical manufacturer that adheres to quality standards at all stages of drug development. Its production facilities meet the requirements of Good Manufacturing Practice (GMP). The quality system complies with the principles of the International Organisation for Harmonisation (ICH Q8, ICH Q9, ICH Q10), ISO 22 000 and ISO 14 001 approaches, and the requirements of Good Distribution Practice (GDP) and Good Storage Practice (GSP). ARTERIUM’s quality management systems comply with the requirements of the international quality management standard ISO 9001.
Our team prioritizes the production of dry lyophilized papaya latex balms, as well as creams, gels, and capsules based on this plant-based raw material because they have no analogs in Ukraine.
In the future, we will expand our product range with new developments that will also be innovative for our market.
The company has found partners and technologies in Ukraine that allow us to grow rare plant materials for the further production of unique herbal remedies.
